HERPES VIRUS (HHV 1) - ANVISA Registration 10287411089

Access comprehensive regulatory information for HERPES VIRUS (HHV 1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411089 and manufactured by CELL MARQUE CORPORATION. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including VIRCELL S.L., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10287411089
Registration Details
ANVISA Registration Number: 10287411089
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Herpes Simplex Vírus1
Risk Class II

Registration Details

10287411089

25351094219201524

30280358000186

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Apr 20, 2015

VIGENTE

09/18/2025 19:00:01